SuperworthNeuroPace market cap NPCE
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $443.1M
- Highest close in our data
- $617.8M
- May 2026
NeuroPace is worth $443.1M at the close on Oct 23, 2026, at $12.91 a share.
That is up 28% over the last year and up 20% over five years.
Its highest close in our data was $617.8M in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $443.1M | $420.1M | $617.8M | −17% |
| 2025 | $533.6M | $283.2M | $579.9M | +68% |
| 2024 | $318.5M | $183.6M | $447.3M | +18% |
| 2023 | $271M | $39.3M | $271M | +630% |
| 2022 | $37.1M | $33.9M | $251.9M | −85% |
| 2021 | $245.1M | $209.8M | $589.1M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest NeuroPace's size, closest first, today.
| Company | Market cap |
|---|---|
| NPCENeuroPace | $443.1M |
| EMBCEmbecta | $380.2M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| INFUInfuSystem | $277.6M |
| UTMDUtah Medical Products | $236.3M |
| PDEXPro DEX | $199.3M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| BVSBioventus | $1.3B |
| Peer median | $552.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on NeuroPace
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.